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egradation of specific protein substrates by the
anaphase-promoting complex/cyclosome (APC)
is critical for mitotic exit. We have identified the
protein 
 
Xenopus 
 
nuclear factor 7 (Xnf7) as a novel APC
inhibitor able to regulate the timing of exit from mitosis.
Immunodepletion of Xnf7 from 
 
Xenopus laevis 
 
egg extracts
accelerated the degradation of APC substrates cyclin B1,
cyclin B2, and securin upon release from cytostatic fac-
tor arrest, whereas excess Xnf7 inhibited APC activity.
D
 
Interestingly, Xnf7 exhibited intrinsic ubiquitin ligase ac-
tivity, and this activity was required for APC inhibition.
Unlike other reported APC inhibitors, Xnf7 did not associ-
ate with Cdc20, but rather bound directly to core subunits
of the APC. Furthermore, Xnf7 was required for spindle
assembly checkpoint function in egg extracts. These data
suggest that Xnf7 is an APC inhibitor able to link spindle
status to the APC through direct association with APC
core components.
 
Introduction
 
Key events in mitosis such as sister chromatid separation and
inactivation of the cyclin-dependent kinase Cdc2 are regulated
by the anaphase-promoting complex/cyclosome (APC), a large
multisubunit ubiquitin ligase that promotes ubiquitylation
and proteasomal degradation of its substrates (Zachariae and
Nasmyth, 1999; Harper et al., 2002; Peters, 2002). Although
the APC was originally identified as a cyclin B ubiquitin ligase
(Irniger et al., 1995; King et al., 1995; Sudakin et al., 1995), it
has since been shown to ubiquitylate numerous cell cycle regu-
latory proteins including cyclin A, securin, Xkid1, Cdc20,
Plk1, and Ase1, as well as regulatory proteins involved in other
cellular processes such as transcription and development
(Hershko and Ciechanover, 1998; Peters, 2002).
The APC is present throughout the cell cycle, but its ac-
tivity is highly regulated. It is active from prometaphase until
late G
 
1
 
, and inactive in S phase and G
 
2
 
 when cyclin B accumu-
lates. Activation of the APC is controlled in part by phosphory-
lation of at least three of its subunits (Cdc16, Cdc23, and
Cdc27) by the mitotic kinases Cdk1/cyclin B and Plk1 (Kotani
et al., 1998; Rudner and Murray, 2000; Golan et al., 2002).
However, the relative importance of these two kinases in the
direct phosphorylation of the APC remains unclear, as data
suggesting both kinases (Golan et al., 2002), only Plk1 (Kotani
et al., 1998), or only Cdk1 (Rudner and Murray, 2000; Kraft et
al., 2003) directly phosphorylate the APC have yet to be recon-
ciled. APC activation is also controlled by the binding of acti-
vators, the WD40-repeat–containing proteins Cdc20 and Cdh1.
In somatic cells, Cdc20 and Cdh1 binding to the APC is regu-
lated, resulting in a peak in APC
 
Cdc20
 
 activity in anaphase and
APC
 
Cdh1
 
 activity in G
 
1
 
 (Fang et al., 1998b; Zachariae et al.,
1998; Kramer et al., 2000). Until recently, it was thought that
Cdh1 was not expressed in the early 
 
Xenopus laevis 
 
embryo,
and that only APC
 
Cdc20
 
 was active (Lorca et al., 1998). A recent
paper suggests, however, that Cdh1 is present in stage VI oo-
cytes, and that it might have a role during the first meiotic cell
cycle (Papin et al., 2004). Although the widely accepted model
for the role of Cdc20/Cdh1in APC activation defines these pro-
teins as essential for substrate recognition (Burton and Sol-
omon, 2001; Pfleger et al., 2001; Schwab et al., 2001), several
recent studies have shown that the core subunits of the APC,
rather than Cdc20/Cdh1, are directly responsible for substrate
recognition (Meyn et al., 2002; Passmore et al., 2003; Yamano
et al., 2004) and that Cdc20/Cdh1 are required for activation of
the APC in a still undefined manner.
Tight regulation of the APC is critical to ensure the ap-
propriate sequential destruction of APC substrates during the
cell cycle. For example, cyclin A is degraded during pro-
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metaphase, and securin, Xkid1, and cyclin B are destroyed
at the metaphase–anaphase transition (Funabiki and Murray,
2000; den Elzen and Pines, 2001; Geley et al., 2001). During
anaphase and telophase, APC
 
Cdh1
 
 is activated and mediates the
destruction of Plk1, Ase1, and Cdc20 (Juang et al., 1997;
Shirayama et al., 1998). The precise sequence of degradative
events that must occur to ensure the proper timing of mitosis
suggests that additional factors control the timing of APC-
mediated ubiquitylation. One such factor is Emi1 (early mitotic
inhibitor 1), an inhibitor of the APC that binds directly to Cdc20
to prevent premature APC activation (Reimann et al., 2001).
Another recently reported APC inhibitor, XErp1 (
 
Xenopus
 
Emi1 related protein 1), also prevents premature APC
 
Cdc20
 
 acti-
vation, although the mechanism of inhibition remains unknown
(Schmidt et al., 2005).
APC
 
Cdc20
 
 activity is also regulated by the spindle check-
point, a mechanism that is critical for the maintenance of ge-
nomic stability and acts by delaying sister chromatid separation
until all chromosomes are properly attached to the mitotic spin-
dle (Amon, 1999; Shah and Cleveland, 2000; Yu, 2002). Upon
activation of the checkpoint at unattached kinetochores, check-
point protein complexes containing BubR1, Bub3, and Mad2
bind to and inhibit the APC activator Cdc20 (Fang et al.,
1998a; Hwang et al., 1998; Sudakin et al., 2001; Tang et al.,
2001; Fang, 2002). Recent studies show that not only are the
spindle checkpoint proteins and Cdc20 spatially regulated but
that spindle checkpoint components are required to recruit the
APC to kinetochores, suggesting that the APC could be regu-
lated directly by the spindle checkpoint (Acquaviva et al.,
2004; Vigneron et al., 2004).
Much of our knowledge of cell cycle progression has
emerged from studies in model systems, including yeast and 
 
X.
laevis
 
. Here, we have used the 
 
Xenopus
 
 egg extract, in which
APC regulation has been extensively analyzed. Unfertilized 
 
Xe-
nopus
 
 eggs are arrested in metaphase of meiosis II due to the
stabilization of cyclin B by an activity known as cytostatic fac-
tor (CSF; Tunquist and Maller, 2003). Crushing the eggs by
centrifugation releases intracellular Ca
 
2
 

 
 stores, activating cal-
cium/calmodulin-dependent protein kinase II and triggering
APC activation and degradation of cyclin B (Lorca et al., 1993).
However, preparing extracts in the presence of EGTA prevents
the activation of calcium/calmodulin-dependent protein kinase
II, allowing high levels of cyclin B to remain and arresting ex-
tracts in meiosis. These CSF-arrested extracts can then be re-
leased from their meiotic state by addition of Ca
 
2
 

 
, leading to
activation of the APC and progression into interphase.
In performing experiments designed to identify novel cy-
clin B2 interactors from 
 
Xenopus
 
 egg extracts that might regu-
late its function, we have uncovered an additional APC inhibi-
tor, 
 
Xenopus
 
 nuclear factor 7 (Xnf7). Xnf7 was originally
cloned during a screen for proteins that accumulate in embry-
onic nuclei during the midblastula transition (Reddy et al.,
1991). Xnf7 is a maternally expressed protein found in oocyte
nuclei. After release into the cytoplasm during maturation,
where it remains throughout the early embryonic cell divisions,
it reenters nuclei at the midblastula transition. El-Hodiri et al.
(1997b) demonstrated that Xnf7 plays a role in dorso-ventral
patterning of the 
 
Xenopus
 
 embryo, but no specific molecular
function has been shown to account for this phenotype.
Here, we demonstrate that Xnf7 has the unexpected abil-
ity to inhibit APC function. Although we isolated Xnf7 via its
affinity for cyclin B2, Xnf7 appears to have universal effects
on APC-dependent ubiquitylation. Immunodepletion of Xnf7
from CSF-arrested egg extracts accelerates the degradation of
cyclin B1, cyclin B2, and securin upon addition of Ca
 
2
 

 
,
thereby accelerating the transition to interphase. Moreover, we
demonstrate that Xnf7 itself has intrinsic ubiquitin ligase activ-
ity, and that this activity is required for inhibition of the APC.
Unlike previously identified inhibitors of APC
 
Cdc20
 
 (e.g., Mad2
and Emi1), Xnf7 does not inhibit APC
 
Cdc20
 
 activity via direct
binding to Cdc20, but rather appears to act independently of
Cdc20 via association with a core APC subunit. We also find
that Xnf7 is required for the spindle assembly checkpoint in
egg extracts. Collectively, our data suggest that Xnf7 inhibits
APC activation in a manner distinct from known APC regula-
tors, likely via interaction with a core APC subunit.
 
Results
 
Xnf7 binds to the cyclin B2 cytoplasmic 
retention sequence (CRS)
 
Previous work from our laboratory and others has demon-
strated that the subcellular localization of cyclins B1 and B2 is
controlled by a region of the cyclin proteins known as the CRS
(Pines and Hunter, 1994). However, the CRSs of these two cy-
clins differ significantly. The cyclin B1 CRS contains a Crm1-
binding nuclear export sequence that promotes nuclear export
of cyclin B1 throughout interphase and is inactivated by phos-
phorylation to allow nuclear accumulation at the onset of mito-
sis (Yang et al., 1998; Hagting et al., 1999). In contrast, the cy-
clin B2 CRS lacks a classical nuclear export sequence and may
serve to anchor cyclin B2 in the cytoplasm (Jackman et al.,
1995). The cyclin B2 CRS, when injected into 
 
Xenopus
 
 oo-
cytes, has also been reported to promote formation of monopo-
lar rather than bipolar spindles, suggesting that this region
might interact with proteins important for spindle polarity
(Yoshitome et al., 1998). Therefore, we sought to purify novel
factors interacting with the cyclin B2 CRS. Upon passage of
 
Xenopus
 
 egg extract over a column of immobilized recombi-
nant cyclin B2 CRS protein (amino acids 94 to 204), we ob-
served a prominent band of 
 

 
80 kD bound specifically to the
cyclin B2 CRS (Fig. 1 A). Analysis by mass spectrometry iden-
tified this band as Xnf7.
 
Depletion of Xnf7 accelerates the 
ubiquitylation of APC substrates and 
mitotic exit
 
Given the previously reported effects of the cyclin B2 CRS on
spindle polarity, we sought to determine if Xnf7 had a discern-
ible role in spindle formation. Toward this end, we produced
anti-Xnf7 antibodies for immunodepletion from 
 
Xenopus
 
 egg
extracts. Affinity-purified Xnf7 antibodies recognized a protein
of 
 

 
80 kD in 
 
Xenopus
 
 XTC lysates and 
 
Xenopus
 
 interphase
and CSF-arrested egg extracts, whereas preimmune IgG did not
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(Fig. 1 B). Antibodies also recognized recombinant Xnf7 and
in vitro translated Xnf7, but did not detect a protein in unpro-
grammed rabbit reticulocyte lysate (RRL; Fig. 1 C).
Immunodepletion of Xnf7 from interphase or CSF ex-
tracts was accomplished with three sequential depletions (Fig.
1 D). The absence of Xnf7 had no detectable effect on bipolar
spindle formation, cyclin B2 localization, or DNA replication
(unpublished data). However, we found that CSF extracts im-
munodepleted of Xnf7 behaved in an unexpected manner. Spe-
cifically, when Xnf7-depleted CSF extracts were released into
interphase by Ca
 
2
 

 
, we found that they transited from the CSF-
arrested state to interphase considerably more rapidly than
mock-depleted (control) extracts, reforming interphase nuclei
40–50 min after Ca
 
2
 

 
 addition compared with 60–80 min in
control extracts (unpublished data). (Note that to start with a
high level of Cdc2/cyclin B activity and monitor its decline, ex-
tracts were first incubated at room temperature for 30 min be-
fore Ca
 
2
 

 
 was added.) Consistent with this observation, deple-
tion of Xnf7 accelerated the degradation of cyclin B1, cyclin
B2, and securin (Fig. 1, E and F). The extracts shown in Fig. 1
(E and F) are distinct, and the timing of exit from CSF arrest
shown here is representative of the timing observed in numer-
ous experiments. Although the absolute timing of exit differed
between extracts, the relative rates of exit under different treat-
ment conditions remained constant.
Because CSF extracts are arrested in metaphase of meio-
sis II, and therefore have characteristics distinct from extracts
that mimic the first embryonic M phase (Tunquist and Maller,
2003), we sought to determine whether depletion of Xnf7 ac-
celerated exit from an extract prepared so as to recapitulate the
first embryonic mitosis or if this acceleration was unique to the
meiotic cell cycle. To this end, we prepared CSF extracts, im-
mediately added Ca
 
2
 

 
 (without prior room temperature incuba-
tion, thereby promoting a more rapid release from the arrest),
and monitored meiotic exit and exit from the following mitosis.
As expected, Xnf7-depleted extracts progressed to interphase
more rapidly than control extracts, degrading cyclin B by 10
min (compared with 20 min; Fig. 2 A) and reforming nuclei at
20 min (compared with 30 min; unpublished data). Once in the
subsequent mitosis, cyclin B degradation (Fig. 2 B, 140 min)
and nuclear reformation (Fig. 2 C, 160 min) in depleted ex-
tracts proceeded ahead of control extracts, suggesting that Xnf7
affects mitotic exit as well as meiotic exit. We also observed
that depletion of Xnf7 from CSF extracts did not cause sponta-
neous release from CSF arrest without the addition of Ca
 
2
 

 
Purified anti-Xnf7 antibodies or purified preimmune IgG were coupled to
protein A–Sepharose and incubated with extracts. Three consecutive deple-
tions were performed and depleted extracts were resolved by SDS-PAGE
and immunoblotted with anti-Xnf7 antibodies. (E) Immunodepletion of Xnf7
accelerates the degradation of cyclin B1 and cyclin B2 during exit from
CSF arrest. CSF extracts were depleted and incubated at 23
 

 
C for 30 min.
CaCl
 
2
 
 was added to extracts, and aliquots removed at the indicated times
after CaCl
 
2
 
 addition were analyzed by SDS-PAGE and immunoblotting
with anti–cyclin B1 or anti–cyclin B2 antibodies. (F) Immunodepletion of
Xnf7 accelerates the degradation of securin during exit from CSF arrest.
CSF extracts were depleted, supplemented with 
 
35
 
S-securin, and incubated
at 23
 

 
C for 30 min. CaCl
 
2
 
 was added to extracts, and aliquots removed at
the indicated times were analyzed by SDS-PAGE and autoradiography.
Figure 1.
 
Immunodepletion of Xnf7 accelerates exit from CSF arrest.
 
(A) Xnf7 interacts with the cyclin B2 CRS. Glutathione-Sepharose beads
were coupled to GST, GST-cyclin B1 CRS, or GST-cyclin B2 CRS and incu-
bated with egg extracts. (left) Beads were washed, and bound material
was conjugated to biotin. Biotinylated material was resolved by SDS-
PAGE, transferred to nitrocellulose, and probed with HRP-streptavidin. The
left lane of each panel shows proteins present on the beads alone; the
right lanes show proteins bound after incubation with extract. (right) Beads
were washed and bound proteins were analyzed by SDS-PAGE and Coo-
massie blue staining. The arrows indicate the 
 

 
80-kD band that was iden-
tified by mass spectrometry as Xnf7. (B) Characterization of Xnf7 antibodies.
 
Xenopus
 
 XTC cell lysate and interphase and CSF-arrested egg extracts
were resolved by SDS-PAGE and immunoblotted with affinity-purified Xnf7
antibodies (left) or purified preimmune IgG (right). (C) Xnf7 wild-type
(Xnf7WT) and Xnf7 mutant 36 (Xnf7m36) expressed in 
 
Escherichia coli
 
,
rabbit reticulocyte lysate (RRL) programmed with Xnf7 (Xnf7 TNT), and un-
programmed RRL were resolved by SDS-PAGE and immunoblotted with affin-
ity-purified Xnf7 antibodies. (D) Immunodepletion of Xnf7 from egg extracts.
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(Fig. 2 D), nor did the depletion of Xnf7 from interphase ex-
tracts induce spontaneous degradation of mitotic substrates
(Fig. 2 E). Therefore, Xnf7 is not required for maintenance of
the CSF arrest. Moreover, depletion of Xnf7 appeared to alter
the rate of cyclin B degradation rather than the lag time until
initiation of degradation in that both Xnf7-depleted and mock-
depleted extracts appeared to initiate degradation immediately
after Ca
 
2
 

 
 addition to CSF extracts.
After finding that immunodepletion of Xnf7 accelerates
the degradation of all APC substrates examined, we wanted to
determine whether this effect was specific to APC substrates or
if the absence of Xnf7 affected the degradation of other pro-
teins, perhaps causing a global acceleration of proteasome-
mediated degradation. To evaluate the effect of Xnf7 immu-
nodepletion on the degradation of a non-APC substrate, we
examined an inhibitor of apoptosis (IAP), a protein that does
not exhibit distinct cell cycle–regulated turnover. IAPs are E3
ubiquitin ligases that can autoubiquitylate in vivo, marking
themselves for destruction by the 26S proteasome (Yang et
al., 2000). IAP autoubiquitylation and accelerated proteasomal
degradation can be triggered by binding the proapoptotic pro-
tein reaper (Holley et al., 2002). Examination of IAP protein
levels in control and Xnf7-depleted extracts supplemented with
reaper revealed that IAP was degraded at nearly the same rate
in the presence or absence of Xnf7 (Fig. 3 A), suggesting that
the acceleration of degradation in the absence of Xnf7 was not
universal and was likely specific to APC substrates. Together,
these data indicated that either Xnf7 or associated codepleted
proteins acted to suppress APC activation.
To determine if removal of Xnf7 itself, rather than associ-
ated proteins, contributed to accelerated APC activation, we
examined the effect of anti-Xnf7 antibody addition to extracts.
Before Ca
 
2
 

 
 addition, we treated CSF extracts with preimmune
IgG, anti-Xnf7 antibodies, or anti-Xnf7 antibodies blocked
with recombinant Xnf7 protein. Extracts treated with anti-Xnf7
antibodies exited meiosis more rapidly (as observed by micros-
copy) and degraded cyclin B more rapidly than extracts treated
with preimmune IgG. Moreover, the effects of the anti-Xnf7
antibodies were neutralized by treatment with recombinant
Xnf7 (Fig. 3 B, left; unpublished data). Note that addition of
anti-Xnf7 antibodies did not alter the amount of Xnf7 in the ex-
tract (Fig. 3 B, right). Together with the effects of immunode-
pletion, these data suggested that Xnf7 protein antagonized
APC-mediated substrate degradation. To address this issue
further, we tested the ability of recombinant wild-type Xnf7
(Xnf7WT) protein to restore the “normal” timing of meiotic
exit in extracts from which Xnf7 had been immunodepleted.
After depletion, CSF extracts were treated with buffer or
Xnf7WT for 30 min at room temperature before Ca
 
2
 

 
 addition.
As expected, Xnf7-depleted extracts degraded cyclin B more
Figure 2. Xnf7 depletion accelerates exit from mitosis but does not cause spontaneous activation of the APC. (A–C) CSF-arrested Xenopus egg extracts
were depleted, supplemented with demembranated sperm chromatin and CaCl2, and incubated at 23C. (A and B) Aliquots removed at the indicated
times after CaCl2 addition were analyzed by SDS-PAGE and immunoblotting with anti–cyclin B2 antibodies. (C) Aliquots of extract were removed at the
indicated times and nuclear morphology was visualized by Hoechst 33258 staining and fluorescence microscopy. (D) CSF extracts were depleted, sup-
plemented with demembranated sperm chromatin, and incubated at 23C. Aliquots removed at the indicated times were analyzed as in A. (E) Interphase
extracts were depleted, supplemented with 35S–cyclin B1, and incubated at 23C. Aliquots removed at the indicated times were analyzed by SDS-PAGE
and autoradiography.
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rapidly than control extracts (Fig. 3 C). Addition of recombi-
nant Xnf7 to depleted extracts restored the normal timing of
APC-mediated substrate degradation, slowing cyclin B degra-
dation to a rate similar to that observed in mock-depleted ex-
tracts. These data reinforce our conclusion that Xnf7 protein has
an inhibitory effect on APC-mediated substrate degradation.
Because addition of recombinant Xnf7WT could complement
the inhibitory activity of the endogenous protein, we reasoned
that the addition of excess recombinant Xnf7WT to egg extracts
might delay or even prevent exit from CSF arrest. To examine
the effect of increasing the Xnf7 concentration in the extract, we
added buffer or Xnf7WT to CSF extracts before Ca
 
2
 

 
 addition.
Although the control extract reformed interphase nuclei 30 min
after Ca
 
2
 

 
 addition, Xnf7WT addition caused a meiotic arrest.
Accordingly, cyclin B was destroyed by 12 min after Ca
 
2
 

 
 ad-
dition in control extract, and was stabilized by addition of
Xnf7WT (Fig. 3 D). These results implicate Xnf7 as an APC
regulator and suggest that it is the removal of Xnf7, not a code-
pleting protein, that leads to accelerated APC-mediated sub-
strate degradation and mitotic exit.
To further confirm that Xnf7 inhibited mitotic exit at the
level of ubiquitylation of APC substrates, not at the level of
degradation by the 26S proteasome, we repeated the experi-
ment described in the previous paragraph in the presence of
methyl-ubiquitin to “trap” cyclin B in its ubiquitylated form.
Although cyclin B ubiquitylation peaked at 10–12 min in the
Figure 3. Xnf7 modulates mitotic exit by altering
ubiquitylation of APC substrates. (A) Xenopus egg
extracts were depleted, supplemented with 35S-IAP,
and treated with reaper and the broad-spectrum
caspase inhibitor zVAD-fmk. Extracts were incubated
at 23C, and aliquots removed at the indicated times
were analyzed by SDS-PAGE and autoradiography
and quantitated by Phosphorimager. (B) Addition of
anti-Xnf7 antibodies mimics immunodepletion of Xnf7.
CSF extracts were treated with purified preimmune
IgG, purified anti-Xnf7 antibodies, or purified anti-
Xnf7 antibodies blocked with a COOH-terminal
fragment of Xnf7 and incubated at 23C for 15 min.
After CaCl2 addition, aliquots were removed at the
indicated times and analyzed by SDS-PAGE and im-
munoblotting with anti–cyclin B2 antibodies (left) or
anti-Xnf7 antibodies (right). (C) Addition of recombi-
nant Xnf7 to Xnf7-depleted extracts restores the nor-
mal timing of cyclin degradation. CSF extracts were
depleted, treated with buffer or recombinant Xnf7,
and incubated at 23C for 30 min. CaCl2 was added
to extracts, and aliquots removed at the indicated
times after CaCl2 addition were analyzed as in B.
(D) Addition of excess Xnf7 delays cyclin B degrada-
tion and mitotic exit. CSF extracts were treated with
buffer or Xnf7WT and incubated at 23C for 20 min.
After CaCl2 addition, aliquots were removed at the
indicated times and analyzed as in B. (E) Excess
Xnf7 delays cyclin B ubiquitylation. Methyl-ubiquitin
was added to the experiment described in D. Ali-
quots were removed at the indicated times, analyzed
by SDS-PAGE and autoradiography, and quantitated
by Phosphorimager.
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control extract, Xnf7WT addition delayed this peak (Fig. 3 E,
16–20 min). Moreover, cyclin B was eventually destroyed in
the control extract (presumably due to ubiquitylation with en-
dogenous ubiquitin following the action of deubiquitylating en-
zymes) but was stabilized by the addition of Xnf7WT.
 
Xnf7 is a ubiquitin ligase
 
In analyzing the Xnf7 sequence, Reddy et al. (1991) noted the
presence of two putative zinc-binding domains and speculated
that Xnf7 might be a transcription factor. However, as one
zinc-binding region contains a consensus sequence typical of
RING domains found in ubiquitin ligases, we suspected that
Xnf7 might function as a ubiquitin ligase (Fig. 4 A). Accord-
ingly, we performed in vitro ubiquitylation assays using puri-
fied E1, E2 (UbcH5a), ubiquitin, and recombinant Xnf7 as the
only source of E3 activity. In addition to testing Xnf7WT, we
constructed Xnf7 RING finger mutants in which conserved
cysteine residues that coordinate zinc binding were replaced by
alanine. Xnf7 mutant 3 (Xnf7m3) contained a mutation at posi-
tion 3 of the RING finger (C160A) and Xnf7 mutant 36
(Xnf7m36) contained mutations at positions 3 and 6 (C160A
and C168A; Fig. 4 A). As with many ubiquitin ligases in vitro,
Xnf7WT was able to autoubiquitylate, converting the single
electrophoretic form of Xnf7 into a polyubiquitylated form
(Fig. 4 B). Mutation of the RING finger inhibited this activity.
We note that Xnf7 was not able to ubiquitylate cyclin B or se-
curin proteins directly (unpublished data), and that Xnf7 cannot
use UbcH10, the ubiquitin-conjugating enzyme that functions
with the APC, as a source of E2 in the autoubiquitylation reac-
tion (Fig. 4 C, left). Note that all E2 enzymes were functional
in E2-thioester assays (Fig. 4 C, right; unpublished data).
Given that Xnf7 has intrinsic ubiquitin ligase activity, we
sought to determine whether or not this activity was required
for its effects on mitotic exit. We therefore compared the ef-
fects of Xnf7WT or Xnf7m36 addition to extracts. As previ-
ously shown in Fig. 3 D, addition of excess Xnf7WT prevented
cyclin B degradation and mitotic exit. Addition of Xnf7m36
did not stabilize cyclin B; rather, cyclin B was degraded (Fig. 4
D), demonstrating that Xnf7’s ligase activity is required for its
effects on mitotic exit. Indeed, addition of excess Xnf7m36
actually accelerated cyclin B degradation relative to buffer-
treated control extracts, suggesting that this mutant protein may
act in a dominant-negative fashion to antagonize the effects of
endogenous Xnf7 (Fig. 4 E). In the presence of methyl-ubiq-
uitin, cyclin B ubiquitylation peaked at 12–16 min after Ca
 
2
 

 
addition in the Xnf7m36-treated extract, whereas Xnf7WT ad-
dition slowed ubiquitylation of cyclin B, delaying the peak un-
til 20 min (Fig. 4 F). As expected, cyclin B was destroyed
eventually in the Xnf7m36-treated extract but was stabilized by
Xnf7WT.
 
Xnf7 inhibits the APC
 
To determine if the inhibitory effect of Xnf7 was exerted di-
rectly on the APC, APC was immunopurified from mitotic egg
extracts using anti-Cdc27 antibodies and treated with recombi-
nant Xnf7WT. APC inhibitors Mad2 and Emi1 have been
shown previously to inhibit the APC in this manner via their
Figure 4. Xnf7 is a ubiquitin ligase and its ligase activity is required for its
effects on mitotic exit. (A) Xnf7 contains a RING finger consensus sequence.
The eight amino acids in bold are the zinc-binding sites of the RING finger.
Xnf7WT, Xnf7 mutant 3 (Xnf7m3) (C160A), and Xnf7 mutant 36 (Xnf7m36)
(C160A and C168A) were produced in bacteria. (B) Xnf7 has ubiquitin li-
gase activity. Xnf7WT (lane 1), Xnf7m3 (lane 2), or Xnf7m36 (lane 3) were
incubated with purified E1, UbcH5a, ubiquitin, and ATP. Lanes 4–7 con-
tained Xnf7WT but lacked one component of the ubiquitylation reaction.
Lane 4, E1; lane 5, UbcH5a; lane 6, ATP; lane 7, ubiquitin. Reac-
tions were incubated at 37C for 2 h and were analyzed by SDS-PAGE and
immunoblotting with anti-ubiquitin or anti-Xnf7 antibodies. White line indi-
cates that intervening lanes have been spliced out. (C) Xnf7 can function
with several E2s but cannot function with UbcH10. (left) Xnf7WT was incu-
bated as in B but with each reaction containing only the E2 indicated. The
absence of E2 in the reaction is indicated (). (right) E2-thioester assays
demonstrate that E2s used are functional. The presence of the E2 alone ()
and the E2 following a 30-min thioester assay () are indicated. Similar re-
sults were obtained for all E2s used (unpublished data). (D) Xnf7’s E3 ligase
activity is required for its effects on mitotic exit. CSF extracts were treated
with buffer, Xnf7WT, or Xnf7m36 and incubated at 23C for 20 min. After
CaCl2 addition, aliquots were removed at the indicated times and analyzed
by SDS-PAGE and immunoblotting with anti–cyclin B2 antibodies. (E)
Xnf7m36 blocks the function of endogenous Xnf7 protein. CSF extracts
were treated with buffer or increasing amounts of Xnf7m36 and incubated
at 23C for 20 min. After CaCl2 addition, aliquots were removed and ana-
lyzed as in D. (F) Xnf7’s ubiquitin ligase activity is required for its effect on
APC substrate ubiquitylation. Methyl-ubiquitin was added to the experiment
described in D. Aliquots were removed at the indicated times, analyzed by
SDS-PAGE and autoradiography, and quantitated by Phosphorimager.
White lines indicate that samples run on the same gel were reordered.
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interactions with Cdc20 (Fang et al., 1998a; Reimann et al.,
2001). As shown in Fig. 5 A, addition of Cdc20 to APC immu-
noprecipitates activated the APC, promoting ubiquitylation of
cyclin B. Preincubation of Cdc20 with MBP-Emi1 signifi-
cantly inhibited the APC; however, preincubation with recom-
binant Xnf7WT or Xnf7m36 had no discernible effect.
Because we had clearly observed an effect of Xnf7 on
APC function in extracts (containing a full complement of cellu-
lar components) and Xnf7’s enzymatic activity was required for
its effect on mitotic exit (Fig. 4, D and F), we reasoned that the
inhibitory effect of Xnf7 on the APC might be evident only un-
der conditions that would allow Xnf7 to function as a ubiquitin
ligase. (Note that the in vitro Xnf7 ubiquitylation assay was per-
formed using UbcH5a and that the purified APC assay contained
only UbcH10. Xnf7 does not function as a ligase with UbcH10
[Fig. 4 C, left].) To this end, UbcH5a was added during the in-
cubation of Xnf7 with APC immunoprecipitates to create
conditions permissive for Xnf7’s enzymatic activity. Whereas
Xnf7WT alone failed to inhibit the APC (Fig. 5 B, lane 2),
Xnf7WT incubated under ubiquitylating conditions did, indeed,
inhibit the purified APC (Fig. 5 B, lane 3). In contrast, Xnf7m36
protein did not inhibit the APC (Fig. 5 B, lane 4), consistent with
a requirement for Xnf7’s enzymatic activity in its direct inhibi-
tion of the APC. The presence of Xnf7 in the assay did not pre-
vent Cdc20 from binding to the APC (unpublished data).
 
Xnf7 interacts with a core subunit of 
the APC
 
Given the inhibitory effects of Xnf7 on the activity of the APC,
we sought to determine how Xnf7 might be exerting its effects.
To investigate the potential association of Xnf7 with the APC,
we separated CSF extracts on 10–40% sucrose gradients and ex-
amined the sedimentation of Xnf7, APC subunits Apc2 and
Cdc27/Apc3, and the APC activator Cdc20. Xnf7 was found
mainly in lower molecular mass fractions of 
 

 
100–250 kD (Fig.
6 A, fractions 2–7) along with Cdc20 (Fig. 6 A, fractions 2–6),
but peaked again with the 
 

 
1.5-MD APC complex in fraction
11, where APC subunits Apc2 and Cdc27/Apc3 also sedimented
(Fig. 6 A). Although a considerable amount of Xnf7 did not
cosediment with APC components, Xnf7 immunoprecipitations
from selected cosedimenting fractions (Fig. 6 A, *) revealed that
Cdc27/Apc3 coimmunoprecipitated with Xnf7 from APC-con-
taining fractions but that Cdc20 did not coimmunoprecipitate
(Fig. 6 B), even in fractions where they were both abundantly
represented. Similarly negative results were obtained when frac-
tions were immunoprecipitated with anti-Cdc20 antibodies and
immunoblotted with anti-Xnf7 antibodies (unpublished data).
These data strongly suggest that Xnf7 acts in a manner distinct
from previously reported APC regulators, most likely through di-
rect interaction with a core APC subunit. That being said, we
note that Xnf7 coimmunoprecipitated equally well with Cdc27
from CSF extracts before and after Ca
 
2
 

 
 addition, suggesting that
Xnf7 functions other than binding (possibly ubiquitin ligase ac-
tivity) are required for Xnf7-mediated APC inhibition (Fig. 6 C).
 
Xnf7 is required for the spindle assembly 
checkpoint
 
Given the ability of Xnf7 to inhibit the APC and the previously
reported localization of Xnf7 to the mitotic spindle (Li et al.,
1994), we sought to determine if Xnf7 might play a role in the
spindle assembly checkpoint. As described by Minshull et al.
(1994), Xenopus extracts can be induced to undergo a spindle
checkpoint arrest after the addition of high concentrations of de-
membranated sperm chromatin and nocodazole. To determine
if Xnf7 might play a role in spindle checkpoint function, CSF
Figure 5. Xnf7 inhibits the APC. (A) RRL (lane 1) or Cdc20 (lanes 2–6)
was incubated (30 min at 23C) with buffer (lanes 1 and 2), 6 M MBP
(lane 3), 6 M MBP-Emi1 (lane 4), 2 M Xnf7WT (lane 5), or 2 M
Xnf7m36 (lane 6). APC was immunopurified from mitotic egg extracts with
anti-Cdc27 beads and incubated with the RRL/Cdc20 mixtures (1 h at
23C). APC beads were washed and assayed for cyclin ubiquitylation ac-
tivity using a 35S-labeled in vitro transcribed-translated Xenopus cyclin B1
fragment (1–126 aa) as a substrate. Samples were run on a 4–15% Tris-
HCl SDS-PAGE gel. Unconjugated cyclin B remaining was quantitated by
Phosphorimager. (B) Similar to A, except that incubations included 5 M
Xnf7WT or Xnf7m36 and were performed under conditions permissive for
Xnf7’s ligase activity where noted (*). Note that more than doubling the
concentration of Xnf7 (compared with that used in A) did not result in APC
inhibition unless the assay was performed under ubiquitylating conditions.
Samples were run on a 4–20% Tris-HCl SDS-PAGE gel. White line indicates
that intervening lanes have been spliced out.
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extracts were preincubated with preimmune IgG or anti-Xnf7
antibodies for 15 min to functionally inhibit Xnf7. After incuba-
tion with high concentrations of sperm chromatin and noco-
dazole, Ca2 was added. Although control extracts lacking
nocodazole did not arrest, extracts containing nocodazole and
preimmune IgG established a spindle checkpoint and therefore
failed to degrade cyclin B (Fig. 7). In contrast, addition of anti-
Xnf7 antibodies effectively overrode the spindle checkpoint, al-
lowing cyclin B degradation and rapid reformation of interphase
nuclei, even in the presence of nocodazole. These data demon-
strate that Xnf7 is required for spindle assembly checkpoint
function in Xenopus egg extracts and suggest that Xnf7 may pro-
vide a link between spindle status and the core APC machinery.
Discussion
Activation of the APC is controlled in part by Cdc20/Cdh1 as
well as their upstream regulators, including BubR1, Bub3,
Mad2, and Emi1 (Zachariae and Nasmyth, 1999; Peters, 2002).
Here, we have identified Xnf7 as a novel inhibitor of APC
function unlikely to act via Cdc20. In addition, we have shown
that Xnf7 itself is a ubiquitin ligase and that its ligase activity
is required for its effects on APC-dependent ubiquitylation.
Because Xnf7 cosedimented and coimmunoprecipitated with
Cdc27, it is attractive to speculate that Xnf7 modifies either
Cdc27 function or the function of other associated core APC
subunits. Furthermore, we have shown that Xnf7 is required for
spindle assembly checkpoint function in Xenopus egg extracts,
suggesting that Xnf7 could be part of a mechanism for direct
regulation of the APC by the spindle checkpoint (a model re-
cently proposed by Acquaviva et al. [2004]).
Identification of Xnf7 as a cyclin B2–
interacting protein
Although we identified Xnf7 as a cyclin B2–interacting pro-
tein, we have shown that Xnf7 also affects the degradation of
cyclin B1 and securin, and, given its inhibitory effect on the
APC, is likely to affect other APC substrates as well. Because
Xnf7 is phosphorylated by Cdc2/cyclin B and mitogen-activated
protein kinase during oocyte maturation (Reddy et al., 1991;
El-Hodiri et al., 1997a), we speculate that the specific interaction
with cyclin B2 might reflect an enzyme–substrate interaction
due to phosphorylation of Xnf7 by Cdc2/cyclin B2.
Regulation of APC activation
Activation of the APC is controlled not only by the binding of
activating proteins Cdc20 and Cdh1 but is also regulated by
phosphorylation of its subunits by mitotic kinases including
Cdc2/cyclin B, Plk1, and PKA (for review see Castro et al.,
2005). One way in which mitotic phosphorylation of APC sub-
units promotes its activation is by facilitating the binding of
Cdc20 (Kramer et al., 2000). In budding yeast, mutation of
Cdk1 sites in APC subunits Cdc16, Cdc23, and Cdc27 inhibits
APC phosphorylation, reduces Cdc20 binding, and delays mi-
totic exit, suggesting that phosphorylation of the APC is essential
Figure 6. Xnf7 associates with the core APC.
(A) Sucrose gradient cosedimentation of Xnf7
and APC subunits. CSF egg extract was frac-
tionated on a 10–40% sucrose gradient.
Fractions were collected and analyzed by
SDS-PAGE and immunoblotting for the indi-
cated proteins. Asterisks indicate the frac-
tions used in the immunoprecipitations in B.
(B) Xnf7 coimmunoprecipitates with Cdc27
from sucrose gradient fractions. Purified anti-
Xnf7 antibodies or purified preimmune IgG
were coupled to protein A–Sepharose and in-
cubated with sucrose gradient fractions 4, 10,
11, and 18 (1 h at 4C). Beads were washed
and bound proteins were analyzed by SDS-
PAGE and immunoblotting with the indicated
antibodies. (C) Xnf7 coimmunoprecipitates
with Cdc27 during CSF arrest and during exit
from arrest. Purified anti-Xnf7 antibodies were
coupled to protein A–Sepharose and incubated
with aliquots of CSF extracts removed at the indicated times after CaCl2 addition (1 h at 4C). Beads were washed and bound proteins were analyzed by
SDS-PAGE and immunoblotting with anti-Cdc27 antibodies.
Figure 7. Xnf7 is required for the spindle assembly checkpoint in egg
extracts. CSF extracts were preincubated with preimmune IgG or anti-Xnf7
antibodies for 15 min at 23C. Demembranated sperm chromatin
(9,000/l) and nocodazole (10 g/ml) were added for 30 min, followed
by the addition of CaCl2. Aliquots removed at the indicated times after
CaCl2 addition were analyzed by SDS-PAGE and immunoblotting with anti–
cyclin B2 antibodies. White line indicates samples run on the same gel were
rearranged. Aliquots were also removed and visualized by Hoechst 33258
staining. Photographs of nuclear morphology at 60 min are shown.
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for its activation (Rudner and Murray, 2000). However, it is
clear that the absence of APC subunit phosphorylation during
interphase does not render the APC impervious to activation in
that APC from interphase extracts can be activated in vitro by
Cdc20 or Cdh1 (Fang et al., 1998b) or in vivo by overexpres-
sion of either activator at any stage in the cell cycle (Visintin et
al., 1997). Thus, multiple mechanisms are likely to cooperate
to ensure that the APC is not activated prematurely. Our data
suggest that Xnf7 participates in one such mechanism.
Xnf7’s ligase activity is required for its 
inhibition of the APC
Consistent with its role as an inhibitor of APC activity, excess
Xnf7 was able to slow degradation of APC substrates and con-
comitantly delay mitotic exit. Intriguingly, this function of Xnf7
required that it be active as a ubiquitin ligase. Moreover, in our
studies using mitotic APC immunoprecipitates to investigate di-
rect inhibition of the APC, inhibition by Xnf7 required the pres-
ence of Xnf7WT in conditions permissive for Xnf7’s enzymatic
activity (E1, UbcH5a, and ubiquitin). It is not yet clear whether
this reflects a requirement for Xnf7 autoubiquitylation in its abil-
ity to regulate the APC or the necessity for ubiquitylation of a
substrate in the APC immunoprecipitates. Although it is formally
possible that Xnf7 could promote ubiquitin-dependent degrada-
tion of APC components, the level of APC subunits examined
has not been found to vary throughout the cell cycle. However,
because ubiquitylation can modify substrate function without tar-
geting it for degradation, it is possible that Xnf7 inhibits APC
function by ubiquitylation of an APC subunit. Indeed, several
ubiquitin ligases have been reported to modify substrate localiza-
tion and/or protein–protein interactions through monoubiquityla-
tion of targets (Hicke, 2001). With regard to the possibility that
either autoubiquitylation or ubiquitylation of APC components
might be important for Xnf7 function, it is interesting to note that
Xnf7 binding to the APC appeared to be equal before and after
release from CSF arrest (when the APC is differentially active).
Moreover, direct association of Xnf7 with the APC was not mea-
surably altered by the spindle checkpoint (unpublished data).
These observations strongly suggest that binding alone is not suf-
ficient for Xnf7-mediated inhibition of the APC. It is attractive to
speculate that Xnf7’s E3 ligase activity may be cell cycle regu-
lated, and thus responsible for its cell cycle–specific actions. Al-
ternatively, or additionally, cell cycle–specific modification of
Xnf7 itself (e.g., phosphorylation or autoubiquitylation) may be
required for it to effectively inhibit the APC.
Recently, it was reported that the core subunits of the
APC, rather than Cdc20/Cdh1, are directly responsible for sub-
strate recognition (Carroll and Morgan, 2002; Meyn et al.,
2002; Passmore et al., 2003; Yamano et al., 2004). Given our
finding that Xnf7 inhibits the APC via association with core
APC subunits, it is plausible that this novel APC inhibitor ex-
erts its effects by interfering with substrate recognition, per-
haps through ubiquitylation of an APC subunit. Ideally, we
would like to address this issue directly by determining if Xnf7
can ubiquitylate proteins present in the anti-Cdc27 precipitate.
Unfortunately, this approach has been hampered thus far by the
high level of ubiquitylation associated with the APC itself.
Although we have identified a role for Xnf7 in regulat-
ing APC activation, previously reported data have implicated
Xnf7 as a regulator of dorsal–ventral polarity establishment
in Xenopus (El-Hodiri et al., 1997b). Because ubiquitin li-
gases may have multiple substrates and therefore participate
in several signaling pathways, it is possible that these two
roles of Xnf7 are entirely distinct. However, it is interesting
to note that reduction-of-function APC mutations in Cae-
norhabditis elegans can disrupt establishment of anterior–
posterior polarity (Rappleye et al., 2002). Thus, Xnf7 could
potentially regulate polarity establishment in Xenopus via its
effects on the APC.
Collectively, the data reported here strongly support a
role for Xnf7 in regulating APC activation and suggest that
Xnf7 participates in the spindle checkpoint. Interestingly, it has
recently been reported that the APC colocalizes with spindle
checkpoint protein complexes at unattached kinetochores and
that the spindle checkpoint machinery is required for the re-
cruitment of the APC to these sites (Acquaviva et al., 2004).
These data suggest that the APC can be regulated directly by
the spindle checkpoint. Given our finding that Xnf7 is required
for spindle checkpoint function in egg extracts, it is attractive
to speculate that Xnf7 might be involved in such a mechanism.
Future identification of direct Xnf7 ubiquitin ligase substrates
should help to elucidate the mechanism of Xnf7-mediated APC
inhibition while helping to further define the links between
spindle function and APC activation.
Materials and methods
Recombinant protein expression
Wild-type Xnf7 was subcloned into the EcoRI and NcoI sites of pGexKG.
Xnf7 RING-finger mutants Xnf7m3 (C160A) and Xnf7m36 (C160A and
C168A) were prepared using the QuikChange Site-Directed Mutagenesis
Kit (Stratagene). To prepare pGexKG-Xnf7C, Xnf7 (257–609 aa) was
PCR amplified and subcloned into the EcoRI and NcoI sites of pGex-KG.
GST fusion proteins expressed in bacteria were purified on glutathione-
Sepharose by standard protocols. Proteins were cleaved with thrombin
and dialyzed against Xnf7 buffer (XB-Xnf7: 100 mM KCl, 25 mM sucrose,
10 mM Hepes, 1 mM MgCl2, and 1 mM DTT, pH 7.8). Uncleaved GST-
Xnf7C was dialyzed against PBS.
CRS affinity chromatography
Glutathione-Sepharose coupled to GST, GST-cyclin B1 CRS, or GST-cyclin
B2 CRS (Yang et al., 1998) were incubated with egg extracts. Bound mate-
rial was biotinylated, resolved by SDS-PAGE, transferred to nitrocellulose,
and probed with HRP-streptavidin. For Coomassie blue staining, bound ma-
terial was washed and resolved by SDS-PAGE. The 80-kD band of inter-
est was analyzed by mass spectrometry at Harvard Microchemistry.
Antibodies and immunodepletions
Rabbit polyclonal antibodies raised against Xnf7C were affinity purified
on glutathione-Sepharose covalently coupled to GST-Xnf7C with dimethyl
pimelimidate. Other antibodies used were as follows: anti–cyclin B1 and
anti–cyclin B2 (Hochegger et al., 2001), anti-APC2 (a gift from G. Fang,
Stanford University, Stanford, CA), anti-ubiquitin (Santa Cruz Biotechnol-
ogy, Inc.), anti-Cdc27 (Santa Cruz Biotechnology, Inc.) for immunoprecip-
itation, anti-Cdc27 (Transduction Laboratories) for immunoblotting, and
anti-Cdc20 (Santa Cruz Biotechnology, Inc.).
For immunodepletions, purified anti-Xnf7 antibodies or preimmune
IgG coupled to protein A–Sepharose were washed in XB-CSF (100 mM
KCl, 50 mM sucrose, 10 mM Hepes, pH 7.7, 5 mM EGTA, 2 mM MgCl2,
and 100 M CaCl2) or ELB (250 mM sucrose, 50 mM KCl, 10 mM
Hepes, pH 7.7, 2.5 mM MgCl2, and 1 mM dithiothreitol), incubated with
extracts (0.2 l beads/l extract, 30 min at 4C), and removed by centrif-
ugation (10,000 rpm, 1 min at 4C).
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Degradation assays
Xenopus egg extracts were prepared as described previously (Murray,
1991). Degradation assays were performed in CSF extracts by adding
CaCl2 to 0.6 mM to initiate anaphase. Human securin (a gift from J. Pines,
Wellcome Trust/Cancer Research UK, Cambridge, UK) was translated in
vitro in the presence of 35S-methionine/cysteine. Aliquots were removed and
analyzed by SDS-PAGE followed by autoradiography (35S-securin) or immu-
noblotting (cyclin B). In all degradation assays, the same amount of protein
was loaded in each gel lane. For interphase extracts, 35S-labeled cyclin B1 or
IAP was added, and aliquots were analyzed as 35S-securin. To stimulate IAP
autoubiquitylation, Drosophila melanogaster reaper was added to extracts
(37.5 M final) with 100 M zVAD-fmk (BIOMOL Research Laboratories).
For antibody addition to extracts, Xnf7 antibodies and preimmune
IgG were concentrated to 3 g/l. Blocked Xnf7 antibodies were pre-
pared by incubating with GST-Xnf7C. After antibody addition (0.3 g an-
tibody/l extract), extracts were incubated at 23C for 15 min before ad-
dition of CaCl2. For Xnf7 protein addition, buffer, Xnf7WT, or Xnf7m36
was added (0.06 g protein/l extract), followed by 15 min incubation
at 23C before addition of CaCl2. Methyl-ubiquitin (3 g/l final) and
35S-labeled Xenopus cyclin B1 fragment (1–126 aa) were added in the in-
dicated experiments. For Xnf7 protein addition to depleted extracts, buffer
or Xnf7WT was added (0.09 g protein/l extract), followed by 30 min
incubation at 23C before CaCl2 addition.
Spindle assembly checkpoints were formed as described previously
(Minshull et al., 1994). DNA was stained with Hoechst 33258 and nuclear
morphology was examined using a microscope (model Axioskop; Carl
Zeiss MicroImaging, Inc.) with a 40 Plan-Neofluar objective (NA 0.75)
or a 100 Plan-Apochromat objective (NA 1.4). Images were captured us-
ing a Pentamax cooled charge-coupled device camera (Princeton Instru-
ments) interfaced with MetaMorph software (Universal Imaging Corp.).
Xnf7 ubiquitylation assay
4 g Xnf7WT, Xnf7m3, or Xnf7m36 were incubated (2 h at 37C) with 50
ng of rabbit E1, 1 g UbcH5a, 10 g ubiquitin, and 3 mM ATP brought to
50 l with buffer (25 mM Hepes, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 10
mM DTT, and 0.05% Triton X-100). Reactions were stopped with SDS sam-
ple buffer, resolved by SDS-PAGE, and analyzed by immunoblotting.
E2-Thioester assay
2 g of each E2 were incubated (30 min at 37C) with 0.5 g of rabbit
E1, 40 g ubiquitin, 10 mM ATP, and 10 mM MgCl2 in a 10-l total vol-
ume. Reactions stopped with SDS sample buffer were resolved on 4–20%
Tris-HCl SDS-PAGE gels and visualized by silver stain.
In vitro APC assay
Anti-Cdc27 antibodies coupled to protein A Dynabeads were washed in
ELB and incubated (2.5 h at 4C) with mitotic extracts. APC beads were
washed with 500 mM KCl, 20 mM Hepes, pH 7.7, and 0.5% NP-40 fol-
lowed by 20 mM Hepes, pH 7.7. Beads were incubated (1 h at 23C)
with RRL or in vitro translated human Cdc20 that had been preincubated
with buffer, 6 M MBP, 6 M MBP-Emi1, or 2–5 M Xnf7WT or
Xnf7m36. The incubation also included 80 ng of rabbit E1, 120 ng
UbcH5a, 10 g of bovine ubiquitin, 3 mM ATP, and 3 mM MgCl2 where
indicated. Beads were washed with 20 mM Hepes, pH 7.7, and assayed
for cyclin ubiquitylation activity with 1.25 g/l of bovine ubiquitin, 60
ng/l E1, 40 ng/l UbcH10, an energy regenerating system, 2 l of 35S-
labeled in vitro translated Xenopus cyclin B1 fragment (1–126 aa) as a
substrate, and 3 l APC beads. Reactions were incubated at 23C for 1 h,
quenched with SDS sample buffer, analyzed by SDS-PAGE and autora-
diography, and quantitated by Phosphorimager.
Sucrose gradient centrifugation
CSF extract diluted 1:3 in XB-CSF without sucrose was cleared at 40,000
rpm and resolved on a 12-ml 10–40% wt/vol sucrose gradient by centrif-
ugation in an SW40 rotor (30,000 rpm, 18 h at 4C). 20 0.5-ml fractions
were collected and analyzed by SDS-PAGE and immunoblotting.
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